Sep 10, 2020 / 06:25PM GMT
Mohit Bansal - Citigroup Inc. Exchange Research - Research Analyst
Great. Good afternoon, everyone. And I think it's still good morning at Amgen as well. So great. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the [biotech] at Citi.
So I'm happy to have Amgen management team today with us. We have Murdo Gordon, EVP and Global -- EVP and Head of Global Commercial Operations at Amgen; Peter Griffith, the CFO of the company; Arvind Sood, the Head IR of the company. Thank you, Murdo, Peter and Arvind, for joining us today.
Peter H. Griffith - Amgen Inc. - Executive VP & CFO
Thanks, Mohit. Great to be here.
Mohit Bansal - Citigroup Inc. Exchange Research - Research Analyst
Great. And those who are listening to us today, if you have any questions, please feel free to e-mail me or send your questions via the webcast, and I'll be happy to just ask that for you anonymously.
So with that, Arvind, over to you, just wanted to give you an opportunity to give a brief overview
Amgen Inc at Citi BioPharma Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot